HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAY-14 4QGF TITLE S.AUREUS TMK IN COMPLEX WITH THE POTENT INHIBITOR COMPOUND 38, 2-(3- TITLE 2 CHLOROPHENOXY)-3-METHOXY-4-{(1R)-1-[(3S)-3-(5-METHYL-2,4-DIOXO-3,4- TITLE 3 DIHYDROPYRIMIDIN-1(2H)-YL)PIPERIDIN-1-YL]PROPYL}BENZOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TMK; COMPND 5 SYNONYM: DTMP KINASE; COMPND 6 EC: 2.7.4.9; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS SUBSP. AUREUS; SOURCE 3 ORGANISM_TAXID: 282458; SOURCE 4 STRAIN: N314; SOURCE 5 GENE: SAR0483, TMK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS THYMIDINE MONPHOSPHATE, SOLUBLE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.B.OLIVIER REVDAT 3 28-FEB-24 4QGF 1 REMARK REVDAT 2 02-JUL-14 4QGF 1 JRNL REVDAT 1 11-JUN-14 4QGF 0 JRNL AUTH S.P.KAWATKAR,T.A.KEATING,N.B.OLIVIER,J.N.BREEN,O.M.GREEN, JRNL AUTH 2 S.Y.GULER,M.F.HENTEMANN,J.T.LOCH,A.R.MCKENZIE,J.V.NEWMAN, JRNL AUTH 3 L.G.OTTERSON,G.MARTINEZ-BOTELLA JRNL TITL ANTIBACTERIAL INHIBITORS OF GRAM-POSITIVE THYMIDYLATE JRNL TITL 2 KINASE: STRUCTURE-ACTIVITY RELATIONSHIPS AND CHIRAL JRNL TITL 3 PREFERENCE OF A NEW HYDROPHOBIC BINDING REGION. JRNL REF J.MED.CHEM. V. 57 4584 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24828090 JRNL DOI 10.1021/JM500463C REMARK 2 REMARK 2 RESOLUTION. 1.83 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 32444 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1648 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.83 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.89 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.31 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2091 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2100 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1995 REMARK 3 BIN R VALUE (WORKING SET) : 0.2084 REMARK 3 BIN FREE R VALUE : 0.2429 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.59 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 96 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3036 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 299 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.47710 REMARK 3 B22 (A**2) : 5.48070 REMARK 3 B33 (A**2) : -2.00360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -8.19770 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.177 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.133 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3177 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4309 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1113 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 81 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 480 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3177 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 426 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4111 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.34 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.26 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QGF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000086022. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 7-8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MONOCHROM. REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROCESS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32586 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.827 REMARK 200 RESOLUTION RANGE LOW (A) : 90.557 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.83 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : 0.48100 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TO OBTAIN THE INHIBITOR BOUND CRYSTAL REMARK 280 FORM OF TMK-S.AUREUS CRYSTALS WERE INITIALLY GROWN IN THE REMARK 280 ABSENCE OF COMPOUND USING THE SITTING DROP METHOD AT 293 K WITH REMARK 280 A RESERVOIR SOLUTION OF 100 MM PCPT (PROPIONATE-CACODYLATE- REMARK 280 BISTRIS PROPANE BUFFER) PH 7-8, 21-24% PEG 3350, 200 MM MG2CL REMARK 280 USING 1:1 PROTEIN:RESERVOIR SOLUTION WITH THE PROTEIN SOLUTION REMARK 280 AT 13 MG/ML. CRYSTALS WERE HARVESTED AND SOAKED OVERNIGHT IN A REMARK 280 SOLUTION CONTAINING 100 MM PCPT, 35% PEG 3350, 200 MM MG2CL AND REMARK 280 1-2 MM OR COMPOUND FROM A 100 MM DMSO STOCK. AFTER SOAKING THE REMARK 280 CRYSTALS WERE CRYOPROTECTED BY SOAKING FOR 15 MINUTES IN REMARK 280 COMPOUND-SOAK SOLUTION SUPPLEMENTED WITH 20% ETHYLENE GLYCOL., REMARK 280 VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.27850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A DIMER. FOR MOLECULE A THE PARTERN IS X, REMARK 300 Y, Z-1. FOR MOLECULE B THE PARTNER IS X, Y, Z+1. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 145 REMARK 465 SER A 146 REMARK 465 ARG A 147 REMARK 465 ASP A 148 REMARK 465 GLN A 149 REMARK 465 ASN A 150 REMARK 465 ARG A 151 REMARK 465 LEU A 152 REMARK 465 MET B 1 REMARK 465 ILE B 143 REMARK 465 LYS B 144 REMARK 465 ASN B 145 REMARK 465 SER B 146 REMARK 465 ARG B 147 REMARK 465 ASP B 148 REMARK 465 GLN B 149 REMARK 465 ASN B 150 REMARK 465 ARG B 151 REMARK 465 LEU B 152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 53 CG CD OE1 OE2 REMARK 470 ASN A 55 CG OD1 ND2 REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 ILE A 143 CG1 CG2 CD1 REMARK 470 LYS A 144 CG CD CE NZ REMARK 470 ASP A 153 CG OD1 OD2 REMARK 470 GLU A 155 CG CD OE1 OE2 REMARK 470 HIS A 172 CG ND1 CD2 CE1 NE2 REMARK 470 ASN A 173 CG OD1 ND2 REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 GLU A 188 CG CD OE1 OE2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 ILE A 205 CG1 CG2 CD1 REMARK 470 HIS B 24 CG ND1 CD2 CE1 NE2 REMARK 470 ASP B 56 CG OD1 OD2 REMARK 470 GLN B 154 CG CD OE1 NE2 REMARK 470 GLU B 155 CG CD OE1 OE2 REMARK 470 LEU B 157 CG CD1 CD2 REMARK 470 LYS B 158 CD CE NZ REMARK 470 GLN B 176 CG CD OE1 NE2 REMARK 470 GLU B 188 CG CD OE1 OE2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 77 -55.41 -124.21 REMARK 500 ARG A 92 138.53 75.79 REMARK 500 TYR A 93 -147.40 -154.03 REMARK 500 TYR A 103 -65.18 -90.28 REMARK 500 GLN A 176 -58.39 -160.70 REMARK 500 ARG B 92 132.60 78.56 REMARK 500 TYR B 93 -143.11 -148.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 32B A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 32B B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QG7 RELATED DB: PDB REMARK 900 RELATED ID: 4QGF RELATED DB: PDB REMARK 900 RELATED ID: 4QGG RELATED DB: PDB REMARK 900 RELATED ID: 4QGH RELATED DB: PDB DBREF 4QGF A 1 205 UNP Q6GJI9 KTHY_STAAR 1 205 DBREF 4QGF B 1 205 UNP Q6GJI9 KTHY_STAAR 1 205 SEQRES 1 A 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 A 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 A 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 A 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 A 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 A 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 A 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 A 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 A 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 A 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 A 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 A 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 A 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 A 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 A 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 A 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE SEQRES 1 B 205 MET SER ALA PHE ILE THR PHE GLU GLY PRO GLU GLY SER SEQRES 2 B 205 GLY LYS THR THR VAL ILE ASN GLU VAL TYR HIS ARG LEU SEQRES 3 B 205 VAL LYS ASP TYR ASP VAL ILE MET THR ARG GLU PRO GLY SEQRES 4 B 205 GLY VAL PRO THR GLY GLU GLU ILE ARG LYS ILE VAL LEU SEQRES 5 B 205 GLU GLY ASN ASP MET ASP ILE ARG THR GLU ALA MET LEU SEQRES 6 B 205 PHE ALA ALA SER ARG ARG GLU HIS LEU VAL LEU LYS VAL SEQRES 7 B 205 ILE PRO ALA LEU LYS GLU GLY LYS VAL VAL LEU CYS ASP SEQRES 8 B 205 ARG TYR ILE ASP SER SER LEU ALA TYR GLN GLY TYR ALA SEQRES 9 B 205 ARG GLY ILE GLY VAL GLU GLU VAL ARG ALA LEU ASN GLU SEQRES 10 B 205 PHE ALA ILE ASN GLY LEU TYR PRO ASP LEU THR ILE TYR SEQRES 11 B 205 LEU ASN VAL SER ALA GLU VAL GLY ARG GLU ARG ILE ILE SEQRES 12 B 205 LYS ASN SER ARG ASP GLN ASN ARG LEU ASP GLN GLU ASP SEQRES 13 B 205 LEU LYS PHE HIS GLU LYS VAL ILE GLU GLY TYR GLN GLU SEQRES 14 B 205 ILE ILE HIS ASN GLU SER GLN ARG PHE LYS SER VAL ASN SEQRES 15 B 205 ALA ASP GLN PRO LEU GLU ASN VAL VAL GLU ASP THR TYR SEQRES 16 B 205 GLN THR ILE ILE LYS TYR LEU GLU LYS ILE HET 32B A 301 37 HET 32B B 301 37 HETNAM 32B 2-(3-CHLOROPHENOXY)-3-METHOXY-4-{(1R)-1-[(3S)-3-(5- HETNAM 2 32B METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL) HETNAM 3 32B PIPERIDIN-1-YL]PROPYL}BENZOIC ACID FORMUL 3 32B 2(C27 H30 CL N3 O6) FORMUL 5 HOH *299(H2 O) HELIX 1 1 GLY A 14 VAL A 27 1 14 HELIX 2 2 VAL A 41 GLU A 53 1 13 HELIX 3 3 ASP A 58 LYS A 77 1 20 HELIX 4 4 LYS A 77 GLU A 84 1 8 HELIX 5 5 TYR A 93 GLN A 101 1 9 HELIX 6 6 GLY A 108 ASN A 121 1 14 HELIX 7 7 SER A 134 LYS A 144 1 11 HELIX 8 8 GLN A 154 GLU A 174 1 21 HELIX 9 9 PRO A 186 GLU A 203 1 18 HELIX 10 10 GLY B 14 VAL B 27 1 14 HELIX 11 11 VAL B 41 GLY B 54 1 14 HELIX 12 12 ASP B 58 LYS B 77 1 20 HELIX 13 13 LYS B 77 GLU B 84 1 8 HELIX 14 14 TYR B 93 GLN B 101 1 9 HELIX 15 15 GLY B 108 ASN B 121 1 14 HELIX 16 16 SER B 134 ILE B 142 1 9 HELIX 17 17 GLN B 154 GLU B 174 1 21 HELIX 18 18 PRO B 186 GLU B 203 1 18 SHEET 1 A 5 VAL A 32 ARG A 36 0 SHEET 2 A 5 VAL A 87 ASP A 91 1 O ASP A 91 N THR A 35 SHEET 3 A 5 ALA A 3 GLU A 8 1 N ALA A 3 O VAL A 88 SHEET 4 A 5 LEU A 127 ASN A 132 1 O ILE A 129 N THR A 6 SHEET 5 A 5 PHE A 178 ASN A 182 1 O LYS A 179 N THR A 128 SHEET 1 B 5 VAL B 32 ARG B 36 0 SHEET 2 B 5 VAL B 87 ASP B 91 1 O LEU B 89 N ILE B 33 SHEET 3 B 5 ALA B 3 GLU B 8 1 N ALA B 3 O VAL B 88 SHEET 4 B 5 LEU B 127 ASN B 132 1 O ILE B 129 N GLU B 8 SHEET 5 B 5 PHE B 178 ASN B 182 1 O VAL B 181 N TYR B 130 CISPEP 1 GLU A 37 PRO A 38 0 -1.67 CISPEP 2 GLU B 37 PRO B 38 0 -6.47 SITE 1 AC1 17 GLU A 37 ARG A 48 VAL A 51 LEU A 52 SITE 2 AC1 17 PHE A 66 SER A 69 ARG A 70 ARG A 92 SITE 3 AC1 17 SER A 97 TYR A 100 GLN A 101 HOH A 413 SITE 4 AC1 17 HOH A 414 HOH A 502 HOH A 503 HIS B 172 SITE 5 AC1 17 SER B 175 SITE 1 AC2 13 GLU B 37 ARG B 48 VAL B 51 PHE B 66 SITE 2 AC2 13 SER B 69 ARG B 70 ARG B 92 SER B 97 SITE 3 AC2 13 TYR B 100 GLN B 101 HOH B 524 HOH B 525 SITE 4 AC2 13 HOH B 526 CRYST1 46.188 90.557 48.448 90.00 101.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021651 0.000000 0.004570 0.00000 SCALE2 0.000000 0.011043 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021096 0.00000